FindTrial
Sign In

Monitoring of Fetal Lung Elasticity by Elastography Between 24 and 39 Weeks

Monitoring of Fetal Lung Elasticity by Elastography Between 24 and 39 Weeks

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03834805
Acronym
ELASTOPULM
Enrollment
74
Registered
2019-02-08
Start date
2019-02-07
Completion date
2021-03-04
Last updated
2021-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant Woman

Brief summary

The objective of the study is to evaluated the evolution of the LLE ratio (Lung to Liver Elastography ratio) during normal pregnancy

Interventions

OTHERlung and liver elastography measurement of fetus

Other: lung and liver elastography measurement of fetus

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* major pregnant women * singleton pregnancy

Exclusion criteria

foetus: * fetal pulmonary disease * fetal liver disease * chromosome fetal abnormalities * fetal growth restriction mother: * BMI\>30 in beginning of pregnancy * premature ruptured membranes * high blood pressure * pre-eclampsia * gestational diabetes

Design outcomes

Primary

MeasureTime frameDescription
Change of Lung to liver Elastography ratio (LLE ratio) between 24 and 39 weeks of amenorrheameasurements at: 24, 28, 32, 36, 39 weeks of amenorrhea (WA)Evolution of the fetal lung elasticity coefficient measured in kilopascals (kPa) compared to the fetal liver elasticity

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026